# Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

> **NCT01086761** · PHASE1 · TERMINATED · sponsor: **Allergan** · enrollment: 32 (actual)

## Conditions studied

- Wet Age-Related Macular Degeneration

## Interventions

- **BIOLOGICAL:** MP0112

## Key facts

- **NCT ID:** NCT01086761
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** The study was terminated due to a company decision following completion of Part A.
- **Last updated:** 2014-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01086761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01086761, "Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01086761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*